Scottsdale, Ariz., (September 24, 2007) – MedCom USA, Inc. (OTC Bulletin Board:EMED) announced today that the SEC has declared effective the Form SB2 registration statement submitted by Card Activation Technologies, Inc.As a result of the effectiveness Card Activation Technologies is in the process of completing its Form 211 application, as filed with the NASD, for a listing of the shares to be traded on the OTC Bulletin Board.
Card Activation Technologies, Inc. is a Chicago-based company that owns a patent covering technology currently used in processing debit cards, gift cards and phone cards.The company believes that many current businesses, including major retailers, phone companies, super markets convenience stores, gas stations and others, are infringing its patent. The company is and will be aggressively pursuing litigation against those infringers.According to a study by the Federal Reserve Bank of Philadelphia in March 2007 indicated that prepaid cards accounted for $181.7 billion in transactions in 2006, and is one of the fasted growing payment systems.
MedCom USA, Inc. provides innovative healthcare and financial transaction solutions for electronically processing HIPAA compliant transactions within the healthcare industry.MedCom USA provides a Web Portal based service package for physicians, clinics, hospitals and dentists that include the following services:Real-time transactions including:Patient Eligibility,Claims Status, Claims Processing, Patient Easy Pay, Credit/Debit Cards, and Check Guarantee.Visit www.medcomusa.com for more information.
Certain matters discussed within this press release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.Although MedCom USA management believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained.Factors that could cause actual results to differ materially from expectations include industry, competitive and technological changes; risks associated with international operations and foreign currency fluctuations; the composition, timing and size of orders from and shipments to major customers; inventory obsolescence; market acceptance of new products and other risks detailed from time to time in MedCom USA, Inc.’s SEC reports, including the company’s most recent 10-K and subsequent 10-Qs.
